Bruce Beutel (Dewpoint)

Af­ter go­ing ‘crazy’ over the sci­ence, Mer­ck signs up a new part­ner in the hunt for an HIV cure

Less than a year af­ter ink­ing a $100 mil­lion li­cens­ing deal with Ger­man gi­ant Bay­er, Dew­point Ther­a­peu­tics has scored an­oth­er big-time con­tract, this time with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.